FI58066C - FLUORHALTIGT TANDVAORMEDEL - Google Patents
FLUORHALTIGT TANDVAORMEDEL Download PDFInfo
- Publication number
- FI58066C FI58066C FI3289/74A FI328974A FI58066C FI 58066 C FI58066 C FI 58066C FI 3289/74 A FI3289/74 A FI 3289/74A FI 328974 A FI328974 A FI 328974A FI 58066 C FI58066 C FI 58066C
- Authority
- FI
- Finland
- Prior art keywords
- fluoride
- mixture
- monofluorophosphate
- fluorine
- ionic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims description 42
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 34
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 21
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 21
- 239000011737 fluorine Substances 0.000 claims description 21
- 229910052731 fluorine Inorganic materials 0.000 claims description 21
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 15
- -1 ion fluoride Chemical class 0.000 claims description 14
- 229940074371 monofluorophosphate Drugs 0.000 claims description 14
- 239000000551 dentifrice Substances 0.000 claims description 5
- 150000002222 fluorine compounds Chemical class 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000003086 colorant Substances 0.000 claims description 3
- 238000005498 polishing Methods 0.000 claims description 2
- 241000567363 Puccinellia maritima Species 0.000 claims 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical class FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 33
- 229940091249 fluoride supplement Drugs 0.000 description 25
- 239000011775 sodium fluoride Substances 0.000 description 16
- 235000013024 sodium fluoride Nutrition 0.000 description 16
- 235000010216 calcium carbonate Nutrition 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 8
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 8
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 7
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000002002 slurry Substances 0.000 description 6
- 239000000606 toothpaste Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000007423 decrease Effects 0.000 description 5
- 210000003298 dental enamel Anatomy 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229910001515 alkali metal fluoride Inorganic materials 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229940034610 toothpaste Drugs 0.000 description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000206575 Chondrus crispus Species 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940124378 dental agent Drugs 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Chemical compound [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002660 anti-spreading effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical class C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- DWYMPOCYEZONEA-UHFFFAOYSA-L fluoridophosphate Chemical compound [O-]P([O-])(F)=O DWYMPOCYEZONEA-UHFFFAOYSA-L 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000004579 marble Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Inorganic materials [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229940079841 sodium copper chlorophyllin Drugs 0.000 description 1
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical class F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Description
Ej55S71 ΓΒΐ KUULUTUSJULKAISU CQOr, TOBA [BJ <11) UTI.ÄGGNINGSSKIIIFT 5 8066 5¾¾¾ C (45) Patentti myönnetty !C 12 .1220Ej55S71 ΓΒΐ NOTICE CQOr, TOBA [BJ <11) UTI.ÄGGNINGSSKIIIFT 5 8066 5¾¾¾ C (45) Patent granted! C 12 .1220
Patent raeddelat (51) KY.ik.Vct.3 A 61 K 7/18 SUOMI —FINLAND (21) P*t*nttlh»k*mu» —P«t*nt*nteknln| 3289/7^ (22) HftktmitpUvl —Ai»6knlnf*dtf 13-11-7^ (23) Alk»pUv&—Glhlghttidag 13-11-7^ (41) Tulkit JulklMksI — Bllvlt effmcllg 17 · 05.75Patent raeddelat (51) KY.ik.Vct.3 A 61 K 7/18 FINLAND —FINLAND (21) P * t * nttlh »k * mu» —P «t * nt * nteknln | 3289/7 ^ (22) HftktmitpUvl —Ai »6knlnf * dtf 13-11-7 ^ (23) Alk» pUv & —Glhlghttidag 13-11-7 ^ (41) Tulkit JulklMksI - Bllvlt effmcllg 17 · 05.75
Pstantti- Ja rekisterihallitus Nihtwwp™,,. kuuLi»ik*un pvm.-Pstantti- and Registry Board Nihtwwp ™ ,,. month »and *
Patent- och registerstyrelsen ' AmBIcm uthgd oeh utUkrHtm publkmd 29-08.80 (32)(33)(31) Pyydetty «ttioHcwt—Bagkrd prioritet l6.11.73Patent and registration authorities' AmBIcm uthgd oeh utUkrHtm publkmd 29-08.80 (32) (33) (31) Requested «ttioHcwt — Bagkrd priority l6.11.73
Iso-Britannia-Storbritannien(GB) 53330/73 Tot eennäyt etty-Styrkt (71) Beecham Group Limited, Beecham House, Great West Road, Brentford,United Kingdom-Storbritannien (GB) 53330/73 Tot aesthet et etty-Styrkt (71) Beecham Group Limited, Beecham House, Great West Road, Brentford,
Middlesex, Engianti-England(GB) (72) Geoffrey Charles Forward, Redhill, Surrey, Susan Ann Duke, Croydon,Middlesex, Engianti-England (GB) (72) Geoffrey Charles Forward, Redhill, Surrey, Susan Ann Duke, Croydon,
Surrey, Melissa Anne Bell, New Maiden, Surrey, Englanti-England(GB) (7^) Berggren Oy Ab (5U) Fluoria sisältävä hampaiden hoitoaine - Fluorhaltigt tandvärdsmedel Tämä keksintö kohdistuu fluoria sisältäviin hampaiden hoitoaineisiin, joilla on hammasmädän syntymistä ehkäisevä vaikutus.The present invention relates to fluorine-containing dentifrices having an anti-tooth decay effect.
Muutamina viime vuosina on esitetty useita ehdotuksia lukuisten erilaisten fluoridiyhdisteiden sisällyttämiseksi suunhoitoseoksiin, kuten hampaanpuhdistusaineisiin hammasmädän syntymistä ehkäisevän vaikutuksen antamiseksi niille. Tämän vaikutuksen uskotaan johtuvan fluori diyhdisteen kyvystä alentaa hammaskiilteen liukoisuutta heikosti happamissa väliaineissa, joita usein esiintyy suussa seurauksena bakteerien vaikutuksesta ruokaan. Hammaskiilteen liukoisuutta alentavan vaikutuksen uskotaan olevan seurauksena hydroksiapatiitin, so. mineraali joka muodostaa pääosan hammaskiilteestä, ja fluoridin välisestä vuorovaikutuksesta fluoriapatiitin muodostamiseksi. Tämä johtuu siitä, että alentavasti vaikuttava liukoisuus kohoaa hydroksiapatiitin fluoridipitoisuuden noustessa. Fluoridin vastaanottaminen ei kuitenkaan ilmeisesti ole ainoa kriteeri, sillä vaikka enemmän fluoria siirtyy hampaan hydroksiapatiittimineraaliin kun käytetään natriumfluori-dia natriummonofluorifosfaatin sijasta, johtaa natriummonofluorifosfaatti (samassa fluorilisäystasossa) hammaskiilteen liukoisuuden suurempaan alenemiseen.In the last few years, several proposals have been made to include a wide variety of fluoride compounds in oral care compositions, such as dentifrices, to give them an anti-tooth effect. This effect is believed to be due to the ability of the fluorine compound to reduce the solubility of tooth enamel in weakly acidic media, which often occurs in the mouth as a result of the action of bacteria on food. The solubility-reducing effect of tooth enamel is believed to be the result of hydroxyapatite, i. a mineral that forms the bulk of tooth enamel, and the interaction between fluoride to form fluoroapatite. This is because the lowering solubility increases as the fluoride content of hydroxyapatite increases. However, the receipt of fluoride is apparently not the only criterion, because although more fluoride is transferred to the dental hydroxyapatite mineral when sodium fluoride is used instead of sodium monofluorophosphate, sodium monofluorophosphate (at the same level of fluoride addition) results in a greater decrease in tooth enamel solubility.
2 580662 58066
Vaikka natriumfluoridi oli ensimmäisiä hampaanhoitoaineisiin lisättyjä fluorideja on se saavuttanut suhteellisen vähäistä käyttöä, koska pitkään on uskottu, että hampaanhoitoaineissa usein käytetyt kalsium-pitoiset kiillotusaineet, erityisesti kalsiumkarbonaatti, ovat yhteensopimattomia ionisten fluoridien, kuten natriumfluoridin kanssa. Näin ollen tiedotettiin jo kauan aikaa sitten, että natriumfluoridin hammasmädän syntyä ehkäisevä vaikutus estyi kalsiumkarbonaatin läsnäollessa, epäilemättä sen vuoksi että uskottiin että nämä aineet reagoisivat ensisijaisesti keskenään liukenemattoman ja inaktiivisen kal-siumfluoridin muodostamiseksi. Tästä syystä ei myöskään natrium-fluoridin käyttö hammasmädän syntyä ehkäisevänä aineena suunhoito-seoksissa ole viime vuosina saavuttanut suosiota, natriummonofluori-fosfaattia on usein käytetty sen sijasta.Although sodium fluoride was the first fluoride added to dentifrices, it has achieved relatively little use because it has long been believed that calcium-containing polishes, particularly calcium carbonate, often used in dentifrices are incompatible with ionic fluorides such as sodium fluoride. Thus, it was long ago reported that the anti-decay effect of sodium fluoride was inhibited in the presence of calcium carbonate, no doubt because these substances were believed to react primarily with each other to form insoluble and inactive calcium fluoride. For this reason, the use of sodium fluoride as an anti-tooth decay agent in oral care compositions has also not gained popularity in recent years, and sodium monofluorophosphate has often been used instead.
Nyt on yllättäen havaittu, että kalsiumkarbonaatin aiheuttama natrium-fluoridin inaktivoituminen ei ole absoluuttinen vaan esiintyy ainoastaan natriumfluoridipitoisuuden kynnysarvoon asti. Yhtä yllättäen on nyt havaittu, että parantunut hammasmädän syntyä ehkäisevä vaikutus saadaan suunhoitoseoksissa, jotka sisältävät kalsiumkarbonaattikiil-lotusainetta, jos nämä sisältävät ionifluoridin ja ionimonofluorifos-faatin seoksen. On havaittu, että tämä parantunut vaikutus on merkittävä, kun 40-80 %> edullisesti 40-55 % seoksen fluoridipitoisuudesta on lisätty ionifluoridina ja 20-60 %, edullisesti 45-60 % on lisätty ionimonofluorifosfaattina.It has now surprisingly been found that inactivation of sodium fluoride by calcium carbonate is not absolute but occurs only up to the sodium fluoride threshold. Equally surprisingly, it has now been found that an improved anti-tooth effect is obtained in oral care compositions containing a calcium carbonate polish if these contain a mixture of ion fluoride and ion monofluorophosphate. It has been found that this improved effect is significant when 40-80%> preferably 40-55% of the fluoride content of the mixture is added as ion fluoride and 20-60%, preferably 45-60% is added as ion monofluorophosphate.
Tämä keksintö kohdistuu näin ollen fluoria sisältävään hampaiden hoitoaineeseen, joka sisältää kalsiumkarbonaattikiillotusainetta ja ionista monofluorifosfaattia, ja keksintö on tunnettu siitä, että hoito-aine lisäksi sisältää ionista fluoridia, jolloin ionifluoridin antama osuus on 40-80 % ja monofluorifosfaatin osuus on 20-60 % seoksen kokonai sfluorista.The present invention is therefore directed to a fluorine-containing dental care composition comprising a calcium carbonate polish and an ionic monofluorophosphate, and the invention is characterized in that the therapeutic agent further comprises ionic fluoride, wherein the ion fluoride provides 40-80% and the monofluorophosphate 20-60% of the mixture. entirely of fluorine.
Ionifluoridi pystyy synnyttämään fluoridi-ioneja vesiliuoksessa. Edullisesti käytetään alkalimetallifluoridia kuten natrium-, kalium- tai litiumfluoridia, jolloin natriumfluoridin käyttö on erityisen edullinen. Muita sopivia fluorideja ovat ammonium-, tina- ja sinkkifluoridit.Ion fluoride is capable of generating fluoride ions in aqueous solution. Preferably, an alkali metal fluoride such as sodium, potassium or lithium fluoride is used, with the use of sodium fluoride being particularly preferred. Other suitable fluorides include ammonium, tin and zinc fluorides.
Ionimonofluorifosfaatti on samoin edullisesti alkalimetallimonofluori-fosfaatti. Natriummonofluorifosfaatti, NaHPO^F, on erityisen edullinen , mutta vastaavia kalium- ja/tai litiumsuoloja voidaan myös käyttää. Sanonta "monofluorifosfaatti" tässä käytettynä tarkoittaa myös mono-fluoripolyfosfaatteja, kuten sellaisia joilla on kaavat Na^p^O^F; 3 58066 K„p309F; Na3KP3OgF; (NH|,)jNaPjOgF ja LijjPjOgF.The ion monofluorophosphate is also preferably an alkali metal monofluorophosphate. Sodium monofluorophosphate, NaHPO 2 F, is particularly preferred, but the corresponding potassium and / or lithium salts may also be used. The term "monofluorophosphate" as used herein also means monofluoropolyphosphates, such as those of the formulas Na 2 P 2 O 2 F; 3,58066 K „p309F; Na3KP3OgF; (NH 1,) jNaPjOgF and LijjPjOgF.
Fluoridin ja mono fluorifosfaatin käytetty kokonaismäärä riippuu jossain määrin hampaanhoitoseoksen tyypistä, mutta sen määrän on oltava tehokas joskaan ei myrkyllinen. Fluoridia ja monofluorifosfaattia on tavallisesti läsnä suunhoitoseoksessa määrässä, joka riittää antamaan 0,025-0,2 % kokonaisfluoria suunhoitoseoksen painosta laskettuna. Edullinen kokonaisfluoriditaso on 0,05-0,12 paino-% seoksesta. Fluori-di ja fluorifosfaatti muodostavat myös edullisesti vastaavasti 40-55 % ja 45-60 % kokonaisfluoripitoisuudesta.The total amount of fluoride and monofluorophosphate used depends to some extent on the type of dental care mixture, but its amount must be effective although not toxic. Fluoride and monofluorophosphate are usually present in the oral care composition in an amount sufficient to provide 0.025-0.2% of total fluorine based on the weight of the oral care composition. The preferred total fluoride level is 0.05-0.12% by weight of the mixture. Fluoride and fluorophosphate also preferably make up 40-55% and 45-60% of the total fluorine content, respectively.
Keksinnön mukainen suunhoitoseos sisältää myös hampaankiillotusaineen, joka on tai sisältää kalsiumkarbonaattia hiovassa muodossa. Tällainen kalsiumkarbonaatti voi olla jompi kumpi geologisista muodoista nimeltään aragoniitti ja kalsiitti tai näiden kahden seos. Edullisia muotoja ovat synteettisesti saostetut liidut, erityisesti vedenpuhdistamo-liitu, joka on saostettu kovasta vedestä kalkilla. Muita kalsiumkarbo-naatteja ovat jauhettu kalkkikivi ja jauhettu marmori tai louhittuja jauhemaisia tuotteita. Kalsiumkarbonaati11a on edullisesti oltava alle 40 mikronin mediaanihalkaisija.The oral care composition of the invention also contains a tooth polish which is or contains calcium carbonate in abrasive form. Such calcium carbonate may be one of the geological forms called aragonite and calcite or a mixture of the two. Preferred forms are synthetically precipitated chalks, in particular water treatment chalk precipitated from hard water with lime. Other calcium carbonates include ground limestone and ground marble or quarried powdered products. The calcium carbonate should preferably have a median diameter of less than 40 microns.
Muita hampaankiillotusaineita voi myös olla läsnä seoksena kalsium-karbonaatin kanssa.Other tooth polishes may also be present in admixture with calcium carbonate.
Voidaan esimerkiksi käyttää veteen liukenemattomia natrium- tai ka-liummetafosfaatteja, hydratoitua tai vedetöntä dikalsiumfosfaattia, kalsiumpyrofosfaattia, sirkoniumsilikaattia tai näiden seoksia. Erityisen käyttökelpoisia kiillotusaine;ta ovat piidioksidin eri muodot, erityisesti US-patentissa n:o 5 538 230 selostetut piidioksidiksero-geelit vaikka näillä kserogeeleillä voi olla keskimääräinen osaskoko-halkaisija, joka on jopa 50 mikronia. Kiillotusainetta tai -aineita voidaan käyttää kokonaismäärässä, joka on 10-99 paino-% keksinnön mukaisesta seoksesta. Nämä seokset ovat edullisesti hammastahnoja, joissa on 20-75 % hampaankiillotusainetta, joskin ne voivat olla jauheiden muodossa, jotka sisältävät 70-99 % kiillotusainetta. Haluttaessa voidaan keksinnön mukaiset seokset valmistaa säikeisiksi tai raidallisiksi hampaanhoitoseoksiksi, erityisesti läpinäkymättömällä sydämellä tai raidoilla (jotka sisältävät kalsiumkarbonaattikiillotus-aineen) läpinäkyvän geelin sisällä tai päällä. Geeli voi sisältää yhtä tai useampaa fluoripitoista ainesosaa ja näissä tapauksissa seos otetaan kokonaisuutena määrättäessä aineksien suhteita yllä seloste- * 58066 tulla tavalla.For example, water-insoluble sodium or potassium metaphosphates, hydrated or anhydrous dicalcium phosphate, calcium pyrophosphate, zirconium silicate, or mixtures thereof may be used. Particularly useful polishes include various forms of silica, especially the silica mixer gels described in U.S. Patent No. 5,538,230, although these xerogels may have an average particle size diameter of up to 50 microns. The polishing agent or agents may be used in a total amount of 10 to 99% by weight of the mixture according to the invention. These compositions are preferably toothpastes with 20-75% tooth polish, although they may be in the form of powders containing 70-99% polish. If desired, the compositions according to the invention can be prepared as fibrous or striped dental compositions, in particular with an opaque core or stripes (containing a calcium carbonate polish) inside or on a transparent gel. The gel may contain one or more fluorine-containing ingredients, and in these cases the mixture is taken as a whole in determining the proportions of the ingredients as described above.
Keksinnön mukaiset suunhoitoseokset sisältävät tavallisesti myös pin-ta-aktiivisia aineita, geeliytymisaineita ja muita lisäaineita kuten makuaineita ja väriaineita.The oral care compositions of the invention usually also contain surfactants, gelling agents and other additives such as flavors and colorants.
Pinta-aktiivinen aine on tavallisesti vesiliukoinen ei-saippua tai synteettinen orgaaninen puhdistava aine. Sopivia pinta-aktiivisia aineita ovat korkeampien rasvahappomonoglyseridimonosulfaattien (esim. natrium-hydratun kookospähkinärasvahappomonoglyseridimonosulfaatin)> korkeampien alkyylisulfaattien (esim. natriumlauryylisulfaatin), al-kyyliaryylisulfonaatin (esim. natriumdodekyylibentseenisulfonaattien), ja korkeampien alkyylisulfoasetaattien (esim. natriumlauryylisulfo-asetaattien) vesiliukoiset suolat. Voidaan myös käyttää alempien ali-faattisten aminokarbonihappojen tyydytettyjen korkeampien alifaattis-ten asyyliamideja, joiden asyyliradikaalissa on 12-16 hiiliatomia, ja joissa aminohappo-osa on peräisin alhaisista alifaattisista tyydytetyistä monoaminokarbonihapoista, joissa on 2-6 hiiliatomia, kuten glysiinin, sarkosiinin, alaniinin, 3-aminopropanoiinihapon ja valiinin rasvahappoamidit, erityisesti N-lauroyyli-, myristoyyli- ja palmito-yylisarkosinaattiyhdisteet. Tavanomaisia non-ionisia puhdistavia aineita voidaan myös lisätä haluttaessa.The surfactant is usually a water-soluble non-soap or synthetic organic detergent. Suitable surfactants include the use of higher alkyl fatty acid monoglyceride monosulfates (e.g., sodium-hydrogenated coconut fatty acid monoglyceride monosulfate)> higher alkyl sulfates (e.g., sodium lauryl sulfate), alkyl aliphatic (about sodium lauryl sulfate), alkyl alkyl sulfonate (e.g., sodium aryl sulfonate), e.g. Saturated higher aliphatic acylamides of lower aliphatic aminocarboxylic acids having 12 to 16 carbon atoms in the acyl radical and having an amino acid moiety derived from low aliphatic saturated monoaminocarboxylic acids having 3 to 6 carbon atoms, glycine, such as glycine can also be used. -aminopropanoic acid and valine fatty acid amides, especially N-lauroyl, myristoyl and palmitoyl sarcosinate compounds. Conventional nonionic cleaning agents may also be added if desired.
Pinta-aktiivisia aineita on tavallisesti läsnä 0,05-10 %, edullisesti 0,5-5 paino-% seoksesta.Surfactants are usually present in an amount of 0.05-10%, preferably 0.5-5% by weight of the mixture.
Hammasjauheita ja -tahnoja valmistetaan tavanomaisella tavalla. Ainesosia voidaan siten sekoittaa kuivassa olotilassa tai lietteinä tai liuoksina.Tooth powders and toothpastes are prepared in a conventional manner. The ingredients can thus be mixed in the dry state or as slurries or solutions.
Nesteet hammastahnassa ovat tavallisesti vesi, glyseroli, sorbitoli tai propyleeniglykoli, sekä näiden sopivat seokset. Tavallisesti on edullista käyttää veden ja glyserolin seosta, edullisesti yhdessä sorbitolin kanssa. Nesteen kokonaismäärä on tavallisesti 20-75 paino-/? valmisteesta. Hammastahnoissa käytetään myös edullisesti geeliytymis-ainetta, kuten luonnon- tai synteettisiä kumeja tai kumin tapaisia aineita, esim. Irlannin sammalta, traganttikumia, natriumkarboksime-tyyliselluloosaa, polyvinyylipyrrolidonia tai tärkkelystä. Irlannin sammal ja natriumkarboksimetyyliselluloosa ovat edullisia geeliyty-misaineita. Kumpitoisuus on tavallisesti jopa 10 % ja edullisesti 0,5-5 paino-?? valmisteesta.Liquids in toothpaste are usually water, glycerol, sorbitol or propylene glycol, as well as suitable mixtures thereof. It is usually preferred to use a mixture of water and glycerol, preferably in combination with sorbitol. The total amount of liquid is usually 20-75 wt / l. the preparation. Gelling agents such as natural or synthetic gums or gums such as Irish moss, gum tragacanth, sodium carboxymethylcellulose, polyvinylpyrrolidone or starch are also preferably used in toothpastes. Irish moss and sodium carboxymethylcellulose are preferred gelling agents. The concentration is usually up to 10% and preferably 0.5-5% by weight. the preparation.
5 580665 58066
Hammastahnan tai hammasjauheen vesilietteen pH on olennaisesti neutraali, kuten noin 6-8. Haluttaessa voidaan lisätä pieni määrä happoa, kuten sitruunahappoa tai emäksistä ainetta.The pH of the aqueous slurry of toothpaste or tooth powder is substantially neutral, such as about 6-8. If desired, a small amount of acid, such as citric acid or a basic substance, may be added.
Voidaan lisätä muita aineita, kuten liukoista sakkariinia, mausteöl-jyjä (esim. piparminttuö.1 jyjä, talvikkipiparminttuöljyjä) , kloroformia, värjääviä tai valkaisevia aineita (esim. titaanidioksidia), säilöntäainetta (esim. natriumbentsoaattia), emulgoivia aineita, hapotta-via aineita (esim. sitruunahappoa), silikoneja, alkoholeja, mentholia, klorofylliyhdisteitä (esim. natriumkupariklorofylliiniä) ja bakteerin-vastaisia aineita (esim. klooriheksidiiniä).Other substances may be added, such as soluble saccharin, spice oils (e.g. peppermint.1 grains, winter peppermint oils), chloroform, colorants or bleaches (e.g. titanium dioxide), preservatives (e.g. sodium benzoate), emulsifiers (e.g. e.g. citric acid), silicones, alcohols, menthol, chlorophyll compounds (e.g. sodium copper chlorophyllin) and antibacterial agents (e.g. chlorhexidine).
Keksinnön mukaiset seokset voivat myös olla muiden suunhoitoseosten muodossa, olennaiset fluori- ja kalsiumkarbonaattiainesosat voidaan esim. lisätä suspensiotyyppisiin suuvesiin tai seoksiin, joita käyttäjä pureksii, esim. purukumiin, tabletteihin, pastilleihin ja lääketab-letteihin. Nämä seokset sisältävät tavanomaisia perusaineita yhdessä sopivien makuaineiden ja makeutusaineiden kanssa ja voidaan muodostaa tavanomaiseen tapaan.The compositions of the invention may also be in the form of other oral care compositions, the essential fluorine and calcium carbonate ingredients may be added, for example, to suspension-type mouthwashes or mixtures which are chewed by the user, e.g. chewing gum, tablets, lozenges and tablets. These mixtures contain conventional bases together with suitable flavors and sweeteners and can be formed in a conventional manner.
Keksinnön mukaisia seoksia selostetaan alla lähemmin esimerkkien avulla:The mixtures according to the invention are described in more detail below by means of examples:
Sisältö Esimerkki 12 3 4 (paino-%)Contents Example 12 3 4 (% by weight)
Glyseroli 25,0 12,5 25,0 12,5Glycerol 25.0 12.5 25.0 12.5
Sorbitoli (70 $:nen liuos) - 12,5 - 12,5Sorbitol ($ 70 solution) - 12.5 - 12.5
Natriumkarboksimetyyliselluloosa 1,0 1,0 1,0 1,0Sodium carboxymethylcellulose
Natriumfluoridi 0,17 0,17 0,17 0,17Sodium fluoride 0.17 0.17 0.17 0.17
Natriummonofluorifosfaatti 0,17 0,17 0,17 0,17Sodium monofluorophosphate 0.17 0.17 0.17 0.17
Natriumlauryylisulfaatti 1,5 1,5 1,5 1,5Sodium laurilsulfate
Natriumsakkariini 0,2 0,2 0,2 0,2Sodium saccharin 0.2 0.2 0.2 0.2
Kalsiumkarbonaatti 45,0 45,0 45,0 45,0Calcium carbonate 45.0 45.0 45.0 45.0
Kalsiumsilikaatti 0,20 0,20 0,20 0,20Calcium silicate 0.20 0.20 0.20 0.20
Makuaine 1,00 1,00 5,0 5,0Flavor 1.00 1.00 5.0 5.0
Vesi lisäys lisäys lisäys lisäys 100 % : in 100 % : in 100 % : in 100 %:inWater increase increase increase increase 100% 100% 100% 100%
Keksinnön tehoa havainnollistetaan alla olevilla esimerkeillä, jotka on suoritettu hydroksiapatiitin hajoamisnopeudelle. Tämä on sopiva malli koska se vastaa hammaskiilteen mineraaliseosta ja hajoaa sei- 6 58066 laisten laimeiden happojen vaikutuksesta, joita muodostuu suussa hajoavasta ruuasta.The efficacy of the invention is illustrated by the following examples, which have been performed on the rate of degradation of hydroxyapatite. This is a suitable model because it is responsible for the mineral mixture of tooth enamel and decomposes under the influence of dilute acids formed from orally decomposing food.
Levyjä valmistettiin hydroksiapatiitista sekoittamalla sitä 10 %:n kanssa polyetyleeniä sitomisominaisuuksien parantamiseksi, minkä jälkeen muovattiin erillisiä levyjä puristamalla 5000 kg:lla 90 sek. ja kuumentamalla sen jälkeen 110°C:ssa. Erillisiä levyjä käsiteltiin hammashoitoaineen lietteellä vesitestiä varten (vesirhammashoitoaine = 3:1) minuutin ajan. Hammashoitoseosta oli varastoitu 2 viikkoa sen valmistuksen jälkeen ja oli esimerkin 3 mukaista yleistä seosta, mutta jossa natriumfluoridin suhtetta natriummonofluorifosfaattiin vaihdeltiin samalla kun fluorin kokonaisväkevyyttä hammashoitoaineessa pidettiin tasaisella tasolla 1000 ppm (0,1 paino-$ kokonaisseoksesta).The sheets were made of hydroxyapatite by mixing it with 10% polyethylene to improve the bonding properties, after which the individual sheets were formed by pressing with 5000 kg for 90 sec. and then heating at 110 ° C. Separate plates were treated with dental care slurry for a water test (water dental care = 3: 1) for one minute. The dental composition was stored for 2 weeks after its preparation and was the general composition of Example 3, but in which the ratio of sodium fluoride to sodium monofluorophosphate was varied while maintaining the total fluorine concentration in the dental agent at a constant level of 1000 ppm (0.1 wt% of the total composition).
Käsitellyt hydroksiapatiittilevyt asetettiin kukin pyörivän propel-lin alle etikkahappopuskuriliuoksessa pH-arvossa 4,65 ja 37°C:ssa tunnin ajan. Prosentuaalinen liukoisuuden aleneminen verrattuna käsittelyyn identtisellä hammashoitoainee11a, joka ei sisältänyt fluoria, määritettiin kussakin tapauksessa. Tulokset on esitetty taulukossa I alla.The treated hydroxyapatite sheets were each placed under a rotating propel in acetic acid buffer at pH 4.65 and 37 ° C for one hour. The percentage decrease in solubility compared to treatment with an identical dental agent that did not contain fluorine was determined in each case. The results are shown in Table I below.
Taulukko ITable I
NaF-pitoisuus F--pitoisuus F-pitoisuus Liukoisuuden % p/p kokonais- NaF:stä (ppm) NaHPO^Fistä aleneminen fluorista (%) 0 - 1000 16,7 3,1 100 900 21,4 6,7 200 800 26,2 22,6 500 500 32,0 30.4 600 400 32,0 46.5 750 250 31,0 100 1000 - 23,8NaF content F - concentration F content Reduction of solubility% w / w of total NaF (ppm) NaHPO 2 F reduction from fluorine (%) 0 - 1000 16.7 3.1 100 900 21.4 6.7 200 800 26.2 22.6 500 500 32.0 30.4 600 400 32.0 46.5 750 250 31.0 100 1000 - 23.8
Tulokset osoittavat että kun 40-80 % kokonaisfluoripitoisuudesta aikaansaadaan alkalimetallifluoridilla paranee liukoisuutta alentava vaikutus hydroksiapatiitille siihen verrattuna, että kaikki fluori on peräisin joko alkalimetallifluoridista tai alkalimetallimonofluori-fosfaatista. Tämä vaikutus on erittäin korostunut kun 50,70 % kokonaisfluoripitoisuudesta aikaansaadaan alkalimetallifluoridilla.The results show that when 40-80% of the total fluorine content is obtained with alkali metal fluoride, the solubility-reducing effect on hydroxyapatite is improved as compared with the fact that all the fluorine is derived from either alkali metal fluoride or alkali metal monofluorophosphate. This effect is very pronounced when 50.70% of the total fluorine content is obtained with alkali metal fluoride.
Sen osoittamiseksi, että liidun ja ionifluoridin alussa tapahtuvan reaktion aiheuttama hammasmädän leviämistä ehkäisevän vaikutuksen in- 7 58066 hibointia voidaan välttää lisäämällä pieniä määriä natriumfluoridia natriummonofluorifosfaattiin, suoritettiin alla olevat kokeet yllä selostetulla menetelmällä käyttäen esimerkin 3 seosta vaihdellen samalla fluoridi/monofluorifosfaattipitoisuuksia esitetyllä tavalla. Tuloksia, joita on saatu käyttäen seoksen vesilietettä (1:3) 2 minuuttia valmistuksen jälkeen (palsta B) on verrattu niihin tuloksiin, jotka johtuvat vastaavan fluoridi/monofluorifosfaattipitoisuuden vesi-liuoksen vaikutuksesta (palsta A).In order to show that the inhibition of the anti-spreading effect caused by the initial reaction of chalk and ion fluoride can be avoided by adding small amounts of sodium fluoride to sodium monofluorophosphate, the experiments below were performed as described above using the fluoride / monofluoride mixture of Example 3. The results obtained using an aqueous slurry of the mixture (1: 3) 2 minutes after preparation (column B) have been compared with those resulting from the action of the aqueous solution of the corresponding fluoride / monofluorophosphate content (column A).
Taulukko IITable II
NaF-väkevyys Na-monofluori- Kokonais- Liuoksen A Lietteen BNaF concentration of Na-monofluoro- Total- Solution A Slurry B
fosfaattiväke- fluoridi- prosentuaa- prosentuaa- vyys väkevyys linen ale- linen aleneminen neminen 5,0xl0~2 5xl0-2 36,0 29,5 Ι,ΙχΙΟ-3 5,lxlO-2 5,2xl0-2 54,1 46,5 Ι,ΟχΙΟ-2 4,lxl0~2 5,lxl0-2 50,9 47,1 l,6xl0~2 3,5xl0-2 5,lxl0-2 52,6 53,6phosphate concentrate fluoride percentage percentage concentration alkaline decrease decrease 5.0x10 ~ 2 5x10-2 36.0 29.5 Ι, ΙχΙΟ-3 5, 1x10-2 5.2x10-2 54.1 46, 5 Ι, ΟχΙΟ-2 4, lxl0 ~ 2 5, lxl0-2 50.9 47.1 l, 6xl0 ~ 2 3.5xl0-2 5, lxl0-2 52.6 53.6
Yllä olevat tulokset osoittavat, että pitämällä kokonais fluoriditaso arvossa 5,1 x 10 M tai 1000 ppm hammastahnassa, mutta lisäämällä natriumfluoridin osuutta natriumfluoridi/natriummonofluorifosfaatti-seoksessa, voidaan fluoridin alussa tapahtuvaa reaktiota liidun kanssa välttää. Tämä ilmenee palstojen A ja B aktiviteettien lähenemises-tä toisiaan, joka osoittaa, että kun fluoridin osuus seoksessa kohoaa alenee kalkin (läsnä ainoastaan lietteessä) aiheuttama fluoridin in-aktivoituminen.The above results show that by maintaining the total fluoride level at 5.1 x 10 M or 1000 ppm in toothpaste, but by increasing the proportion of sodium fluoride in the sodium fluoride / sodium monofluorophosphate mixture, the initial reaction of fluoride with chalk can be avoided. This is evident from the convergence of the activities of columns A and B, which shows that as the proportion of fluoride in the mixture increases, the inactivation of fluoride by lime (present only in the slurry) decreases.
Claims (3)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5333073 | 1973-11-16 | ||
GB5333073A GB1435624A (en) | 1973-11-16 | 1973-11-16 | Oral hygiene composition |
Publications (3)
Publication Number | Publication Date |
---|---|
FI328974A7 FI328974A7 (en) | 1975-05-17 |
FI58066B FI58066B (en) | 1980-08-29 |
FI58066C true FI58066C (en) | 1980-12-10 |
Family
ID=10467406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI3289/74A FI58066C (en) | 1973-11-16 | 1974-11-13 | FLUORHALTIGT TANDVAORMEDEL |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS6028808B2 (en) |
AT (1) | AT353972B (en) |
BE (1) | BE822236A (en) |
CA (1) | CA1031265A (en) |
DE (1) | DE2454136B2 (en) |
DK (1) | DK137705B (en) |
FI (1) | FI58066C (en) |
FR (1) | FR2251309B1 (en) |
GB (1) | GB1435624A (en) |
IE (1) | IE40103B1 (en) |
NO (1) | NO142653C (en) |
SE (1) | SE413223B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4152419A (en) * | 1977-05-25 | 1979-05-01 | Colgate-Palmolive Company | Dentifrice composition |
EP0007170B1 (en) * | 1978-07-12 | 1981-06-17 | Beecham Group Plc | Method of inhibiting corrosion of aluminium tubes by toothpastes |
GB2068727B (en) * | 1979-12-19 | 1983-09-14 | Colgate Palmolive Co | Dental cream comprising sodium fluoride sodium monofluorophosphate and dicalcium phosphate |
GB2074859B (en) * | 1980-04-25 | 1984-10-17 | Colgate Palmolive Co | Opaque dental creams |
US4348382A (en) | 1980-12-05 | 1982-09-07 | Colgate-Palmolive Company | Dentifrice composition |
US4425324A (en) * | 1981-05-11 | 1984-01-10 | Colgate-Palmolive Company | Hazed toothpaste |
IN157400B (en) * | 1981-10-06 | 1986-03-22 | Beecham Inc | |
NZ202128A (en) * | 1981-10-24 | 1985-02-28 | Beecham Group Plc | Detergent composition containing translucent gels |
FR2542198B1 (en) * | 1983-03-11 | 1985-12-27 | Rizhskij Med Inst | MEDICINAL AND PROPHYLACTIC TOOTHPASTE GEL WITH ANTICARIAL ACTION |
FR2542199B1 (en) * | 1983-03-11 | 1986-01-10 | Rizhskij Med Inst | MEDICINE FOR THE TREATMENT OF DENTAL CARIES |
FR2542197B1 (en) * | 1983-03-11 | 1985-12-20 | Rizhskij Med Inst | DRUG AND PROPHYLACTIC DENTAL ANTICARIA IN THE FORM OF GRANULES |
FR2542196B1 (en) * | 1983-03-11 | 1986-03-14 | Rizhskij Med Inst | DRUG TOOTHPASTE AND ANTICARIAL PROPHYLACTIC |
DE3504178A1 (en) * | 1985-02-07 | 1986-08-14 | Blendax Werke Schneider Co | TOOTHPASTE |
FR2613899B1 (en) * | 1987-03-06 | 1991-03-29 | Kuhn Sa | AGRICULTURAL MACHINE FOR WORKING THE SOIL HAVING A ROTOR OBLABLY EXTENDING TO ITS DIRECTION OF MOVEMENT |
DE3841775A1 (en) * | 1988-12-12 | 1990-06-13 | Henkel Kgaa | TOOTHPASTE |
DE102010047319A1 (en) | 2010-10-01 | 2011-11-10 | Schott Ag | Tooth enamel gentle cleanser, useful as toothpaste, comprises rounded glass particles |
WO2023141708A1 (en) * | 2022-01-26 | 2023-08-03 | Visionaturolab Inc. | Oral care composition comprising treated aragonite calcium carbonate |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3634585A (en) * | 1966-08-11 | 1972-01-11 | Colgate Palmolive Co | Dentifrice preparation |
-
1973
- 1973-11-16 GB GB5333073A patent/GB1435624A/en not_active Expired
-
1974
- 1974-11-05 IE IE2269/74A patent/IE40103B1/en unknown
- 1974-11-11 AT AT900874A patent/AT353972B/en not_active IP Right Cessation
- 1974-11-13 FI FI3289/74A patent/FI58066C/en active
- 1974-11-14 NO NO744104A patent/NO142653C/en unknown
- 1974-11-14 BE BE150546A patent/BE822236A/en not_active IP Right Cessation
- 1974-11-14 SE SE7414346A patent/SE413223B/en not_active IP Right Cessation
- 1974-11-14 DE DE19742454136 patent/DE2454136B2/en not_active Ceased
- 1974-11-15 CA CA213,877A patent/CA1031265A/en not_active Expired
- 1974-11-15 DK DK594574AA patent/DK137705B/en not_active Application Discontinuation
- 1974-11-16 JP JP49132442A patent/JPS6028808B2/en not_active Expired
- 1974-12-19 FR FR7442006A patent/FR2251309B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR2251309B1 (en) | 1979-07-06 |
ATA900874A (en) | 1976-09-15 |
FI328974A7 (en) | 1975-05-17 |
BE822236A (en) | 1975-05-14 |
NO142653C (en) | 1980-09-24 |
AT353972B (en) | 1979-12-10 |
JPS6028808B2 (en) | 1985-07-06 |
IE40103B1 (en) | 1979-03-14 |
DE2454136A1 (en) | 1975-05-28 |
SE413223B (en) | 1980-05-12 |
GB1435624A (en) | 1976-05-12 |
CA1031265A (en) | 1978-05-16 |
FR2251309A1 (en) | 1975-06-13 |
DE2454136B2 (en) | 1977-12-22 |
AU7523774A (en) | 1976-05-13 |
NO142653B (en) | 1980-06-16 |
DK137705B (en) | 1978-04-24 |
SE7414346L (en) | 1975-05-20 |
IE40103L (en) | 1975-05-16 |
DK594574A (en) | 1975-07-14 |
NO744104L (en) | 1975-06-16 |
FI58066B (en) | 1980-08-29 |
JPS5088244A (en) | 1975-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3966863A (en) | Oral hygiene compositions | |
EP0092929B2 (en) | Oral hygiene compositions | |
US4358437A (en) | Compositions | |
FI58066C (en) | FLUORHALTIGT TANDVAORMEDEL | |
US4891211A (en) | Stable hydrogen peroxide-releasing dentifice | |
AU597384B2 (en) | Oral hygiene composition containing an antibacterial agent | |
US4988500A (en) | Oral compositions | |
US5885553A (en) | Hydrophobic agents for use in oral care products | |
US4193988A (en) | Oral hygiene compositions | |
GB2188548A (en) | Oral hygiene compositions | |
NO163667B (en) | DENTAL AND ORAL CARE. | |
US3937803A (en) | Flavored dental creams | |
CA1128420A (en) | Methyloxathiazinone dioxide in oral compositions | |
MX2012005853A (en) | Non-aqueous, single tube dentrifice whitening compositions, methods of use and manufacture thereof. | |
CA1333885C (en) | Toothpaste | |
KR100738263B1 (en) | Dentrifice compositions comprising talc | |
EP0012008B1 (en) | Toothpaste | |
US5885556A (en) | Tartar control oral compositions | |
JPH0832619B2 (en) | Aqueous toothpaste composition | |
KR980008208A (en) | A stable peroxide-containing dentifrice composition | |
CA1126162A (en) | Dentifrice containing amorphous precipitated silica free of fluoride scavenger | |
GB1560913A (en) | Dentifrices |